Articles tagged with "European Union"

European Commission Approves Upadacitinib for Psoriatic Arthritis & Ankylosing Spondylitis

February 4, 2021 • By Michele B. Kaufman, PharmD, BCGP

U.S. & E.U. Differ on Filgotinib for RA

September 14, 2020 • By Michele B. Kaufman, PharmD, BCGP

Canada & E.U. Approve Upadacitinib for RA

January 28, 2020 • By Michele B. Kaufman, PharmD, BCGP

EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray

August 8, 2018 • By Michele B. Kaufman, PharmD, BCGP

EU Approves Marketing for Ixekizumab in Adults with PsA

February 7, 2018 • By Michele B. Kaufman, PharmD, BCGP

European Commission Approves Subcutaneous Belimumab for SLE; FDA Safety Alert for Febuxostat

November 29, 2017 • By Michele B. Kaufman, PharmD, BCGP

Report on EU’s Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar?

October 17, 2017 • By Vanessa Caceres

Spanish Drugmaker Fears Disruption if EMA Moves from Britain

July 4, 2016 • By Emma Pinedo

Etanercept Biosimilar Approved in EU, Plus FDA Reviews Brodalumab for Plaque Psoriasis

February 3, 2016 • By Michele B. Kaufman, PharmD, BCGP

Greece Bans Export of 25 Drugs after Pharmacists’ Supply Warnings

July 15, 2015 • By Lefteris Karagiannopoulos